United States Antibody Market Report & Forecast 2021-2027

Publisher Name :
Date: 08-Sep-2021
No. of pages: 108
Inquire Before Buying

United States Antibody Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (KG)

United States Antibody Market Segment Percentages, By Type, 2020 (%)

- IgM

- IgG

- IgA

- Other

United States Antibody Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (KG)

United States Antibody Market Segment Percentages, By Application, 2020 (%)

- Therapeutic

- Research

- Diagnostic

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Antibody revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Antibody revenues share in United States market, 2020 (%)

Key companies Antibody sales in United States market, 2016-2021 (Estimated), (KG)

Key companies Antibody sales share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Roche

- Johnson and Johnson

- Merck

- Novartis

- AbbVie

- Amgen

- Pfizer

- Bayer

- Lilly

- Bristol-Myers Squibb

- GlaxoSmithKline

- Biogen

- AstraZeneca

- Sanofi

- Alexion Pharmaceuticals

- Seattle Genetics

United States Antibody Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Antibody Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Antibody Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Antibody Overall Market Size
2.1 United States Antibody Market Size: 2021 VS 2027
2.2 United States Antibody Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Antibody Sales: 2016-2027
3 Company Landscape
3.1 Top Antibody Players in United States Market
3.2 Top United States Antibody Companies Ranked by Revenue
3.3 United States Antibody Revenue by Companies
3.4 United States Antibody Sales by Companies
3.5 United States Antibody Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Antibody Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Antibody Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antibody Players in United States Market
3.8.1 List of Tier 1 Antibody Companies in United States
3.8.2 List of Tier 2 and Tier 3 Antibody Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Antibody Market Size Markets, 2021 & 2027
4.1.2 IgM
4.1.3 IgG
4.1.4 IgA
4.1.5 Other
4.2 By Type - United States Antibody Revenue & Forecasts
4.2.1 By Type - United States Antibody Revenue, 2016-2021
4.2.2 By Type - United States Antibody Revenue, 2022-2027
4.2.3 By Type - United States Antibody Revenue Market Share, 2016-2027
4.3 By Type - United States Antibody Sales & Forecasts
4.3.1 By Type - United States Antibody Sales, 2016-2021
4.3.2 By Type - United States Antibody Sales, 2022-2027
4.3.3 By Type - United States Antibody Sales Market Share, 2016-2027
4.4 By Type - United States Antibody Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Antibody Market Size, 2021 & 2027
5.1.2 Therapeutic
5.1.3 Research
5.1.4 Diagnostic
5.2 By Application - United States Antibody Revenue & Forecasts
5.2.1 By Application - United States Antibody Revenue, 2016-2021
5.2.2 By Application - United States Antibody Revenue, 2022-2027
5.2.3 By Application - United States Antibody Revenue Market Share, 2016-2027
5.3 By Application - United States Antibody Sales & Forecasts
5.3.1 By Application - United States Antibody Sales, 2016-2021
5.3.2 By Application - United States Antibody Sales, 2022-2027
5.3.3 By Application - United States Antibody Sales Market Share, 2016-2027
5.4 By Application - United States Antibody Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Overview
6.1.3 Roche Antibody Sales and Revenue in United States Market (2016-2021)
6.1.4 Roche Antibody Product Description
6.1.5 Roche Recent Developments
6.2 Johnson and Johnson
6.2.1 Johnson and Johnson Corporation Information
6.2.2 Johnson and Johnson Overview
6.2.3 Johnson and Johnson Antibody Sales and Revenue in United States Market (2016-2021)
6.2.4 Johnson and Johnson Antibody Product Description
6.2.5 Johnson and Johnson Recent Developments
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Overview
6.3.3 Merck Antibody Sales and Revenue in United States Market (2016-2021)
6.3.4 Merck Antibody Product Description
6.3.5 Merck Recent Developments
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Overview
6.4.3 Novartis Antibody Sales and Revenue in United States Market (2016-2021)
6.4.4 Novartis Antibody Product Description
6.4.5 Novartis Recent Developments
6.5 AbbVie
6.5.1 AbbVie Corporation Information
6.5.2 AbbVie Overview
6.5.3 AbbVie Antibody Sales and Revenue in United States Market (2016-2021)
6.5.4 AbbVie Antibody Product Description
6.5.5 AbbVie Recent Developments
6.6 Amgen
6.6.1 Amgen Corporation Information
6.6.2 Amgen Overview
6.6.3 Amgen Antibody Sales and Revenue in United States Market (2016-2021)
6.6.4 Amgen Antibody Product Description
6.6.5 Amgen Recent Developments
6.7 Pfizer
6.7.1 Pfizer Corporation Information
6.7.2 Pfizer Overview
6.7.3 Pfizer Antibody Sales and Revenue in United States Market (2016-2021)
6.7.4 Pfizer Antibody Product Description
6.7.5 Pfizer Recent Developments
6.8 Bayer
6.8.1 Bayer Corporation Information
6.8.2 Bayer Overview
6.8.3 Bayer Antibody Sales and Revenue in United States Market (2016-2021)
6.8.4 Bayer Antibody Product Description
6.8.5 Bayer Recent Developments
6.9 Lilly
6.9.1 Lilly Corporation Information
6.9.2 Lilly Overview
6.9.3 Lilly Antibody Sales and Revenue in United States Market (2016-2021)
6.9.4 Lilly Antibody Product Description
6.9.5 Lilly Recent Developments
6.10 Bristol-Myers Squibb
6.10.1 Bristol-Myers Squibb Corporation Information
6.10.2 Bristol-Myers Squibb Overview
6.10.3 Bristol-Myers Squibb Antibody Sales and Revenue in United States Market (2016-2021)
6.10.4 Bristol-Myers Squibb Antibody Product Description
6.10.5 Bristol-Myers Squibb Recent Developments
6.11 GlaxoSmithKline
6.11.1 GlaxoSmithKline Corporation Information
6.11.2 GlaxoSmithKline Overview
6.11.3 GlaxoSmithKline Antibody Sales and Revenue in United States Market (2016-2021)
6.11.4 GlaxoSmithKline Antibody Product Description
6.11.5 GlaxoSmithKline Recent Developments
6.12 Biogen
6.12.1 Biogen Corporation Information
6.12.2 Biogen Overview
6.12.3 Biogen Antibody Sales and Revenue in United States Market (2016-2021)
6.12.4 Biogen Antibody Product Description
6.12.5 Biogen Recent Developments
6.13 AstraZeneca
6.13.1 AstraZeneca Corporation Information
6.13.2 AstraZeneca Overview
6.13.3 AstraZeneca Antibody Sales and Revenue in United States Market (2016-2021)
6.13.4 AstraZeneca Antibody Product Description
6.13.5 AstraZeneca Recent Developments
6.14 Sanofi
6.14.1 Sanofi Corporation Information
6.14.2 Sanofi Overview
6.14.3 Sanofi Antibody Sales and Revenue in United States Market (2016-2021)
6.14.4 Sanofi Antibody Product Description
6.14.5 Sanofi Recent Developments
6.15 Alexion Pharmaceuticals
6.15.1 Alexion Pharmaceuticals Corporation Information
6.15.2 Alexion Pharmaceuticals Overview
6.15.3 Alexion Pharmaceuticals Antibody Sales and Revenue in United States Market (2016-2021)
6.15.4 Alexion Pharmaceuticals Antibody Product Description
6.15.5 Alexion Pharmaceuticals Recent Developments
6.16 Seattle Genetics
6.16.1 Seattle Genetics Corporation Information
6.16.2 Seattle Genetics Overview
6.16.3 Seattle Genetics Antibody Sales and Revenue in United States Market (2016-2021)
6.16.4 Seattle Genetics Antibody Product Description
6.16.5 Seattle Genetics Recent Developments
7 United States Antibody Production Capacity, Analysis
7.1 United States Antibody Production Capacity, 2016-2027
7.2 Antibody Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Antibody Supply Chain Analysis
9.1 Antibody Industry Value Chain
9.2 Antibody Upstream Market
9.3 Antibody Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Antibody Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Antibody in United States Market
Table 2. Top Antibody Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Antibody Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Antibody Revenue Share by Companies, 2016-2021
Table 5. United States Antibody Sales by Companies, (KG), 2016-2021
Table 6. United States Antibody Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Antibody Price (2016-2021) & (USD/KG)
Table 8. Manufacturers Antibody Product Type
Table 9. List of Tier 1 Antibody Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Antibody Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of IgM
Table 12. Major Manufacturers of IgG
Table 13. By Type - United States Antibody Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Antibody Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Antibody Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Antibody Sales (KG), 2016-2021
Table 17. By Type - United States Antibody Sales (KG), 2022-2027
Table 18. By Application - United States Antibody Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Antibody Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Antibody Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Antibody Sales (KG), 2016-2021
Table 22. By Application - United States Antibody Sales (KG), 2022-2027
Table 23. Roche Corporation Information
Table 24. Roche Description and Major Businesses
Table 25. Roche Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 26. Roche Antibody Product
Table 27. Roche Recent Developments
Table 28. Johnson and Johnson Corporation Information
Table 29. Johnson and Johnson Description and Major Businesses
Table 30. Johnson and Johnson Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 31. Johnson and Johnson Antibody Product
Table 32. Johnson and Johnson Recent Developments
Table 33. Merck Corporation Information
Table 34. Merck Description and Major Businesses
Table 35. Merck Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 36. Merck Antibody Product
Table 37. Merck Recent Developments
Table 38. Novartis Corporation Information
Table 39. Novartis Description and Major Businesses
Table 40. Novartis Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 41. Novartis Antibody Product
Table 42. Novartis Recent Developments
Table 43. AbbVie Corporation Information
Table 44. AbbVie Description and Major Businesses
Table 45. AbbVie Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 46. AbbVie Antibody Product
Table 47. AbbVie Recent Developments
Table 48. Amgen Corporation Information
Table 49. Amgen Description and Major Businesses
Table 50. Amgen Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 51. Amgen Antibody Product
Table 52. Amgen Recent Developments
Table 53. Pfizer Corporation Information
Table 54. Pfizer Description and Major Businesses
Table 55. Pfizer Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 56. Pfizer Antibody Product
Table 57. Pfizer Recent Developments
Table 58. Bayer Corporation Information
Table 59. Bayer Description and Major Businesses
Table 60. Bayer Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 61. Bayer Antibody Product
Table 62. Bayer Recent Developments
Table 63. Lilly Corporation Information
Table 64. Lilly Description and Major Businesses
Table 65. Lilly Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 66. Lilly Antibody Product
Table 67. Lilly Recent Developments
Table 68. Bristol-Myers Squibb Corporation Information
Table 69. Bristol-Myers Squibb Description and Major Businesses
Table 70. Bristol-Myers Squibb Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 71. Bristol-Myers Squibb Antibody Product
Table 72. Bristol-Myers Squibb Recent Developments
Table 73. GlaxoSmithKline Corporation Information
Table 74. GlaxoSmithKline Description and Major Businesses
Table 75. GlaxoSmithKline Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 76. GlaxoSmithKline Antibody Product
Table 77. GlaxoSmithKline Recent Developments
Table 78. Biogen Corporation Information
Table 79. Biogen Description and Major Businesses
Table 80. Biogen Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 81. Biogen Antibody Product
Table 82. Biogen Recent Developments
Table 83. AstraZeneca Corporation Information
Table 84. AstraZeneca Description and Major Businesses
Table 85. AstraZeneca Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 86. AstraZeneca Antibody Product
Table 87. AstraZeneca Recent Developments
Table 88. Sanofi Corporation Information
Table 89. Sanofi Description and Major Businesses
Table 90. Sanofi Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 91. Sanofi Antibody Product
Table 92. Sanofi Recent Developments
Table 93. Alexion Pharmaceuticals Corporation Information
Table 94. Alexion Pharmaceuticals Description and Major Businesses
Table 95. Alexion Pharmaceuticals Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 96. Alexion Pharmaceuticals Antibody Product
Table 97. Alexion Pharmaceuticals Recent Developments
Table 98. Seattle Genetics Corporation Information
Table 99. Seattle Genetics Description and Major Businesses
Table 100. Seattle Genetics Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 101. Seattle Genetics Antibody Product
Table 102. Seattle Genetics Recent Developments
Table 103. Antibody Production Capacity (KG) of Key Manufacturers in United States Market, 2019-2021 (KG)
Table 104. United States Antibody Capacity Market Share of Key Manufacturers, 2019-2021
Table 105. Antibody Market Opportunities & Trends in United States Market
Table 106. Antibody Market Drivers in United States Market
Table 107. Antibody Market Restraints in United States Market
Table 108. Antibody Raw Materials
Table 109. Antibody Raw Materials Suppliers in United States Market
Table 110. Typical Antibody Downstream
Table 111. Antibody Downstream Clients in United States Market
Table 112. Antibody Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Antibody Product Picture
Figure 2. Antibody Segment by Type
Figure 3. Antibody Segment by Application
Figure 4. United States Antibody Market Overview: 2020
Figure 5. United States Antibody Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Antibody Revenue, 2016-2027 (US$, Mn)
Figure 7. Antibody Sales in United States Market: 2016-2027 (KG)
Figure 8. The Top 3 and 5 Players Market Share by Antibody Revenue in 2020
Figure 9. IgM Product Picture
Figure 10. IgG Product Picture
Figure 11. IgA Product Picture
Figure 12. Other Product Picture
Figure 13. By Type - United States Antibody Sales Market Share, 2016-2027
Figure 14. By Type - United States Antibody Revenue Market Share, 2016-2027
Figure 15. By Type - United States Antibody Price (USD/KG), 2016-2027
Figure 16. Therapeutic
Figure 17. Research
Figure 18. Diagnostic
Figure 19. By Application - United States Antibody Sales Market Share, 2016-2027
Figure 20. By Application - United States Antibody Revenue Market Share, 2016-2027
Figure 21. By Application - United States Antibody Price (USD/KG), 2016-2027
Figure 22. Roche Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Johnson and Johnson Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Merck Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Novartis Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. AbbVie Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Amgen Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Pfizer Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Bayer Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Lilly Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Bristol-Myers Squibb Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. GlaxoSmithKline Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Biogen Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. AstraZeneca Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. Sanofi Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. Alexion Pharmaceuticals Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. Seattle Genetics Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. United States Antibody Production Capacity (KG), 2016-2027
Figure 39. Antibody Industry Value Chain
Figure 40. Marketing Channels
  • Global Antibody Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136
    According to our LPI (LP Information) latest study, the global Antibody market size was valued at US$ 8893.3 million in 2023. With growing demand in downstream market, the Antibody is forecast to a readjusted size of US$ 12940 million by 2030 with a CAGR of 5.5% during review period. The research report highlights the growth potential of the global Antibody market. Antibody are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......
  • Global Antibody Production Market Status and Outlook 2023-2028
    Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 121
    Antibody production involves preparation of antigen samples and their safe injection into laboratory or farm animals so as to evoke high expression levels of antigen-specific antibodies in the serum, which can then be recovered from the animal. Polyclonal antibodies are recovered directly from serum (bleeds). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (mil......
  • Global Antibody Production Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Antibody Production market: According to our latest research, the global Antibody Production market looks promising in the next 5 years. As of 2022, the global Antibody Production market was estimated at USD 9193.37 million, and it's anticipated to reach USD 17140.24 million in 2028, with a CAGR of 10.94% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global ......
  • Global Antibody Production Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 117
    Report Overview: The Global Antibody Production Market Size was estimated at USD 8847.90 million in 2022 and is projected to reach USD 14207.79 million by 2029, exhibiting a CAGR of 7.00% during the forecast period. This report provides a deep insight into the global Antibody Production market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key mark......
  • Global Anti-CD20 Monoclonal Antibodies Professional Survey Report 2023, Forecast to 2028
    Published: 30-Nov-2023        Price: US 3280 Onwards        Pages: 100
    Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......
  • Global Anti-CD20 Monoclonal Antibodies Market Research Report 2023, Forecast to 2028
    Published: 30-Nov-2023        Price: US 2680 Onwards        Pages: 165
    Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......
  • Monoclonal Antibody Industry Forecasts - China Focus
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 92
    This study focuses on China's Monoclonal Antibody industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services.......
  • Monoclonal Antibody Companies in China
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 73
    This study focuses on China's Monoclonal Antibody industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions......
  • Monoclonal Antibody Markets in China
    Published: 27-Nov-2023        Price: US 4000 Onwards        Pages: 219
    China's demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, i......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs